Company CrisBio Science Technology

ALGENEX has signed its first commercial license agreement with FATRO

Sep 08 2015

ALGENEX S.L. announced today that it has signed its first commercial license agreement with the Italian animal health vaccines company FATRO S.p.A. for the worldwide use and industrial production of a recombinant vaccine with CrisBioTM technology.